ATHE vs JNJ: Which Stock is Better?

Side-by-side comparison of Alterity Therapeutics Ltd and Johnson & Johnson in 2026

Comparison Updated:

ATHE

Alterity Therapeutics Ltd

$3.30

JNJ

Johnson & Johnson

$218.21

Key Metrics Comparison

MetricATHEJNJWinner
Market Cap$59.81M$525.73BJNJ
P/E RatioN/A21.10JNJ
EPS (TTM)$N/A$10.34JNJ
Revenue Growth0.8%0.1%ATHE
Gross Margin97.7%68.4%ATHE

Analyze ATHE

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ATHE or JNJ a better investment?

Comparing ATHE and JNJ: Alterity Therapeutics Ltd has a market cap of $59.81M while Johnson & Johnson has $525.73B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ATHE and JNJ?

ATHE (Alterity Therapeutics Ltd) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ATHE or JNJ?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ATHE or JNJ?

ATHE has higher revenue growth at 0.8% vs 0.1% for JNJ.

Which company is more profitable: ATHE or JNJ?

Alterity Therapeutics Ltd (ATHE) has higher gross margins at 97.7% compared to 68.4% for JNJ.

Which is the larger company: ATHE or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $525.73B compared to $59.81M for ATHE.

Should I buy ATHE or JNJ in 2026?

Both ATHE and JNJ have investment merit. ATHE trades at $3.30 while JNJ trades at $218.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ATHE and JNJ stock?

Key differences: Market Cap ($59.81M vs $525.73B), P/E Ratio (N/A vs 21.1x), Revenue Growth (0.8% vs 0.1%), Gross Margin (97.7% vs 68.4%).

Popular Stock Comparisons